Published in Drugs on December 01, 2000
Nociceptor sensitization in pain pathogenesis. Nat Med (2010) 2.13
A double-blind, randomized, multicenter, Italian study of frovatriptan versus almotriptan for the acute treatment of migraine. J Headache Pain (2011) 1.22
A double-blind, randomized, multicenter, Italian study of frovatriptan versus rizatriptan for the acute treatment of migraine. J Headache Pain (2010) 1.21
Neurologic bases for comorbidity of balance disorders, anxiety disorders and migraine: neurotherapeutic implications. Expert Rev Neurother (2011) 1.13
Does sumatriptan cross the blood-brain barrier in animals and man? J Headache Pain (2009) 0.88
Psilocybin dose-dependently causes delayed, transient headaches in healthy volunteers. Drug Alcohol Depend (2011) 0.87
Why pharmacokinetic differences among oral triptans have little clinical importance: a comment. J Headache Pain (2010) 0.86
Distribution of 5-HT1B and 5-HT1D receptors in the inner ear. Brain Res (2010) 0.84
The pharmacological management of migraine, part 1: overview and abortive therapy. P T (2008) 0.84
Effects of the CGRP receptor antagonist BIBN4096BS on capsaicin-induced carotid haemodynamic changes in anaesthetised pigs. Br J Pharmacol (2003) 0.83
Parenteral vs. oral sumatriptan and naratriptan: plasma levels and efficacy in migraine. a comment. J Headache Pain (2007) 0.83
Recent advances in the diagnosis and management of migraine. BMJ (2006) 0.83
What can be learned from the history of recurrence in migraine? A comment. J Headache Pain (2009) 0.82
Interindividual variability of oral sumatriptan pharmacokinetics and of clinical response in migraine patients. Eur J Clin Pharmacol (2008) 0.81
The 5-HT1F receptor agonist lasmiditan as a potential treatment of migraine attacks: a review of two placebo-controlled phase II trials. J Headache Pain (2012) 0.81
Is there an inherent limit to acute migraine treatment efficacy? J Headache Pain (2009) 0.81
The effect of rizatriptan, ergotamine, and their combination on human peripheral arteries: a double-blind, placebo-controlled, crossover study in normal subjects. Br J Clin Pharmacol (2002) 0.81
Published and not fully published double-blind, randomised, controlled trials with oral naratriptan in the treatment of migraine: a review based on the GSK Trial Register. J Headache Pain (2011) 0.80
Thermoreversible nanoethosomal gel for the intranasal delivery of Eletriptan hydrobromide. J Mater Sci Mater Med (2016) 0.80
Is there an inherent limit to the efficacy of calcitonin gene-related peptide receptor antagonists in the acute treatment of migraine? A comment. J Headache Pain (2009) 0.80
Frovatriptan is Effective and Well Tolerated in Korean Migraineurs: A Double-Blind, Randomized, Placebo-Controlled Trial. J Clin Neurol (2010) 0.80
Discovery of MK-3207: A Highly Potent, Orally Bioavailable CGRP Receptor Antagonist. ACS Med Chem Lett (2010) 0.80
Sumatriptan inhibition of N-type calcium channel mediated signaling in dural CGRP terminal fibres. Neuropharmacology (2012) 0.80
Subcutaneous delivery of sumatriptan in the treatment of migraine and primary headache. Patient Prefer Adherence (2012) 0.79
Effects of current and prospective antimigraine drugs on the porcine isolated meningeal artery. Naunyn Schmiedebergs Arch Pharmacol (2006) 0.79
Triptans attenuate capsaicin-induced CREB phosphorylation within the trigeminal nucleus caudalis: a mechanism to prevent central sensitization? J Headache Pain (2011) 0.79
Are the current IHS guidelines for migraine drug trials being followed? J Headache Pain (2010) 0.79
Distribution of 5-HT1F Receptors in Monkey Vestibular and Trigeminal Ganglion Cells. Front Neurol (2016) 0.78
Sumatriptan does not change calcitonin gene-related peptide in the cephalic and extracephalic circulation in healthy volunteers. J Headache Pain (2009) 0.77
The optimal management of headaches in children and adolescents. Ther Adv Neurol Disord (2016) 0.77
The complex actions of sumatriptan on rat dural afferents. Cephalalgia (2012) 0.77
Involvement of 5-HT1B receptors in triptan-induced contractile responses in guinea-pig isolated iliac artery. Naunyn Schmiedebergs Arch Pharmacol (2004) 0.76
Gi-protein-coupled 5-HT1B/D receptor agonist sumatriptan induces type I hyperalgesic priming. Pain (2016) 0.76
Efficacy and pharmacokinetic activity of frovatriptan compared to rizatriptan in patients with moderate-to-severe migraine. Drug Des Devel Ther (2014) 0.76
Pharmacogenomics and migraine: possible implications. J Headache Pain (2008) 0.76
The pharmacological profile and clinical prospects of the oral 5-HT1F receptor agonist lasmiditan in the acute treatment of migraine. Ther Adv Neurol Disord (2015) 0.76
Mechanisms mediating nitroglycerin-induced delayed-onset hyperalgesia in the rat. Neuroscience (2016) 0.75
An in vitro interethnic comparison of monoamine oxidase activities between Japanese and Caucasian livers using rizatriptan, a serotonin receptor 1B/1D agonist, as a model drug. Br J Clin Pharmacol (2003) 0.75
Triptans and troponin: a case report. Orphanet J Rare Dis (2009) 0.75
Almotriptan in the treatment of migraine. Neuropsychiatr Dis Treat (2007) 0.75
Placebo response in migraine. Eur J Clin Pharmacol (2010) 0.75
Protective Roles of N-acetyl Cysteine and/or Taurine against Sumatriptan-Induced Hepatotoxicity. Adv Pharm Bull (2016) 0.75
Hair analysis for detection of triptans occasionally used or overused by migraine patients-a pilot study. Eur J Clin Pharmacol (2016) 0.75
Verisimilitude (or "truthlikeness") as an alternative to pro and cons: migraine and cluster headache mechanisms. J Headache Pain (2010) 0.75
International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). Pharmacol Rev (1994) 7.11
Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine. Neuropharmacology (1986) 5.83
Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism. Circulation (1995) 2.25
Selective vasoconstriction in carotid vascular bed by methysergide: possible relevance to its antimigraine effect. Eur J Pharmacol (1974) 2.04
Cardiac renin and angiotensins. Uptake from plasma versus in situ synthesis. Hypertension (1994) 1.87
Ergotamine in the acute treatment of migraine: a review and European consensus. Brain (2000) 1.52
The effects of mianserin hydrochloride on the vascular responses evoked by 5-hydroxytryptamine and related vasoactive substances. Eur J Pharmacol (1971) 1.49
Craniovascular selectivity of eletriptan and sumatriptan in human isolated blood vessels. Neurology (2000) 1.47
Porcine carotid vascular effects of eletriptan (UK-116,044): a new 5-HT1B/1D receptor agonist with anti-migraine activity. Naunyn Schmiedebergs Arch Pharmacol (1998) 1.42
Bradykinin-induced contraction of human peripheral airways mediated by both bradykinin beta 2 and thromboxane prostanoid receptors. Am J Respir Crit Care Med (1994) 1.41
Coronary side-effect potential of current and prospective antimigraine drugs. Circulation (1998) 1.36
Mediation of 5-hydroxytryptamine-induced tachycardia in the pig by the putative 5-HT4 receptor. Br J Pharmacol (1990) 1.31
Computer programs for the radioactive microsphere technique. Determination of regional blood flows and other haemodynamic variables in different experimental circumstances. Comput Programs Biomed (1980) 1.29
5-Carboxamide tryptamine, a compound with high affinity for 5-hydroxytryptamine1 binding sites, dilates arterioles and constricts arteriovenous anastomoses. Br J Pharmacol (1985) 1.25
5-Hydroxytryptamine-induced tachycardia in the pig: possible involvement of a new type of 5-hydroxytryptamine receptor. Br J Pharmacol (1988) 1.25
On serotonin and migraine: a clinical and pharmacological review. Cephalalgia (1993) 1.23
The effect of ergotamine on tissue blood flow and the arteriovenous shunting of radioactive microspheres in the head. Br J Pharmacol (1978) 1.22
Canine distemper virus in seals. Nature (1988) 1.22
Redistribution by 5-hydroxytryptamine of carotid arterial blood at the expense of arteriovenous anastomotic blood flow. J Physiol (1982) 1.15
Mechanism of selective cardiac vagolytic action of pancuronium bromide. Specific blockade of cardiac muscarinic receptors. Eur J Pharmacol (1970) 1.15
Oxidative epithelial damage produces hyperresponsiveness of human peripheral airways. Am J Respir Crit Care Med (1994) 1.14
Characterization of putative 5-HT7 receptors mediating tachycardia in the cat. Br J Pharmacol (1997) 1.14
Mannose 6-phosphate receptor-mediated internalization and activation of prorenin by cardiac cells. Hypertension (1997) 1.14
Role of some biogenic substances in migraine and relevant mechanism in antimigraine action of ergotamine--studies in an experimental model for migraine. Headache (1974) 1.12
Antimigraine drug sumatriptan increases blood flow velocity in large cerebral arteries during migraine attacks. Neurology (1992) 1.10
Analysis of the heart rate effects of 5-hydroxytryptamine in the cat; mediation of tachycardia by 5-HT1-like receptors. Naunyn Schmiedebergs Arch Pharmacol (1985) 1.10
5-HT1-like receptors: a time to bid goodbye. Trends Pharmacol Sci (1998) 1.09
Cardiovascular profile of pimobendan, a benzimidazole-pyridazinone derivative with vasodilating and inotropic properties. Eur J Pharmacol (1986) 1.06
Further characterization, by use of tryptamine and benzamide derivatives, of the putative 5-HT4 receptor mediating tachycardia in the pig. Br J Pharmacol (1991) 1.05
The current endothelin receptor classification: time for reconsideration? Trends Pharmacol Sci (1994) 1.03
Antimigraine drugs and cranial arteriovenous shunting in the cat. Neurology (1980) 1.01
Excitatory 5-hydroxytryptamine receptors in the cat urinary bladder are of the M- and 5-HT2-type. J Auton Pharmacol (1985) 1.00
N-(3-acetylaminophenyl)piperazine hydrochloride (BEA 1654), a putative 5-HT1 agonist, causes constriction of arteriovenous anastomoses and dilatation of arterioles. Eur J Pharmacol (1985) 1.00
A comparison of cardiovascular and smooth muscle effects of 5-hydroxytryptamine and 5-carboxamidotryptamine, a selective agonist of 5-HT1 receptors. Arch Int Pharmacodyn Ther (1985) 1.00
Tissue blood flow and localization of arteriovenous anastomoses in pigs with microspheres of four different sizes. Pflugers Arch (1985) 1.00
Angiotensin II induces hypertrophy of human airway smooth muscle cells: expression of transcription factors and transforming growth factor-beta1. Am J Respir Cell Mol Biol (1998) 1.00
Haemodynamic changes and acetylcholine-induced hypotensive responses after NG-nitro-L-arginine methyl ester in rats and cats. Br J Pharmacol (1991) 0.99
Angiotensin II-mediated growth and antigrowth effects in cultured neonatal rat cardiac myocytes and fibroblasts. J Mol Cell Cardiol (1997) 0.98
Role of 5-HT1-like receptors in the reduction of porcine cranial arteriovenous anastomotic shunting by sumatriptan. Br J Pharmacol (1991) 0.97
Redistribution of carotid artery blood flow by 5-HT: effects of the 5-HT2 receptor antagonists ketanserin and Wal 1307. Eur J Pharmacol (1984) 0.97
Serum levels of tumor necrosis factor determine the fatal or non-fatal course of endotoxic shock. Immunol Lett (1991) 0.97
Endothelin receptors in the human coronary artery, ventricle and atrium. A quantitative autoradiographic analysis. Naunyn Schmiedebergs Arch Pharmacol (1993) 0.97
Arteriovenous shunting and migraine. Res Clin Stud Headache (1978) 0.97
Comparative effects of the antimigraine drugs sumatriptan and ergotamine on the distribution of cardiac output in anaesthetized pigs. Cephalalgia (1992) 0.96
Conjugation of camptothecins to poly-(L-glutamic acid). Ann N Y Acad Sci (2000) 0.96
Necrotizing enterocolitis in the newborn infant. Am J Surg (1972) 0.96
Heterogeneity of endothelin/sarafotoxin receptors mediating contraction of the human isolated saphenous vein. Eur J Pharmacol (1993) 0.96
Effects of methysergide and 5-hydroxytryptamine on carotid blood flow distribution in pigs: further evidence for the presence of atypical 5-HT receptors. Br J Pharmacol (1984) 0.95
Ergotamine-induced constriction of cranial arteriovenous anastomoses in dogs pretreated with phentolamine and pizotifen. Cephalalgia (1983) 0.95
5-Hydroxytryptamine-induced contractions of the human isolated saphenous vein: involvement of 5-HT2 and 5-HT1D-like receptors, and a comparison with grafted veins. Naunyn Schmiedebergs Arch Pharmacol (1992) 0.94
Identification of acetylcholine, histamine, and 5-hydroxytryptamine in Girardinia heterophylla (Decne.). Can J Physiol Pharmacol (1966) 0.94
Pharmacological aspects of experimental headache models in relation to acute antimigraine therapy. Eur J Pharmacol (1999) 0.94
Canine external carotid vasoconstriction to methysergide, ergotamine and dihydroergotamine: role of 5-HT1B/1D receptors and alpha2-adrenoceptors. Br J Pharmacol (1999) 0.94
Analysis of alpha 1L-adrenoceptor pharmacology in rat small mesenteric artery. Br J Pharmacol (1999) 0.94
Investigation of the role of 5-HT1B and 5-HT1D receptors in the sumatriptan-induced constriction of porcine carotid arteriovenous anastomoses. Br J Pharmacol (1999) 0.94
Low-dose aspirin inhibits platelet-induced contraction of the human isolated coronary artery. A role for additional 5-hydroxytryptamine receptor antagonism against coronary vasospasm? Circulation (1994) 0.93
Clinical and experimental effects of sumatriptan in humans. Trends Pharmacol Sci (1993) 0.93
Bradykinin potentiation by angiotensin-(1-7) and ACE inhibitors correlates with ACE C- and N-domain blockade. Hypertension (2001) 0.92
The canine external carotid vasoconstrictor 5-HT1 receptor: blockade by 5-HT1B (SB224289), but not by 5-HT1D (BRL15572) receptor antagonists. Eur J Pharmacol (1998) 0.92
The effects of alinidine, an N-allyl derivative of clonidine, on regional myocardial perfusion and performance in the pig with or without atrial pacing. Eur J Pharmacol (1980) 0.92
On the psychology of drinking: being thirsty and perceptually ready. Br J Psychol (2001) 0.91
Carotid haemodynamics in pigs during infusions of 8-OH-DPAT: reduction in arteriovenous shunting is mediated by 5-HT1-like receptors. Br J Pharmacol (1989) 0.91
Vasoconstriction by in situ formed angiotensin II: role of ACE and chymase. Cardiovasc Res (1999) 0.91
Regional and systemic haemodynamic changes evoked by 5-hydroxytryptamine in awake and anaesthetized rabbits. Eur J Pharmacol (1978) 0.91
Nicorandil-induced changes in the distribution of cardiac output and coronary blood flow in pigs. Naunyn Schmiedebergs Arch Pharmacol (1987) 0.91
Acute systemic and regional hemodynamic effects of felodipine, a new calcium antagonist, in conscious renal hypertensive rabbits. J Cardiovasc Pharmacol (1984) 0.91
Effects of MDL 72222 and methiothepin on carotid vascular responses to 5-hydroxytryptamine in the pig: evidence for the presence of "5-hydroxytryptamine1-like" receptors. Naunyn Schmiedebergs Arch Pharmacol (1986) 0.90
The role of several alpha(1)- and alpha(2)-adrenoceptor subtypes mediating vasoconstriction in the canine external carotid circulation. Br J Pharmacol (2001) 0.90
Interactions of GR127935, a 5-HT(1B/D) receptor ligand, with functional 5-HT receptors. Naunyn Schmiedebergs Arch Pharmacol (1997) 0.89
Positive inotropy mediated via CGRP receptors in isolated human myocardial trabeculae. Eur J Pharmacol (2000) 0.89
5-HT1-like receptors mediate contractions of the rabbit saphenous vein. Eur J Pharmacol (1990) 0.89
5-Hydroxytryptamine stimulates human isolated atrium but not ventricle. Eur J Pharmacol (1993) 0.89
Mediation of 5-HT-induced internal carotid vasodilatation in GR127935- and ritanserin-pretreated dogs by 5-HT7 receptors. Naunyn Schmiedebergs Arch Pharmacol (2000) 0.89
Determinants of coronary reserve in rats subjected to coronary artery ligation or aortic banding. Cardiovasc Res (1996) 0.89
Sequential release of tumour necrosis factor, platelet activating factor and eicosanoids during endotoxin shock in anaesthetized pigs: protective effects of indomethacin. Br J Pharmacol (1991) 0.89
Regional myocardial perfusion and wall thickness and arteriovenous shunting after ergotamine administration to pigs with a fixed coronary stenosis. J Cardiovasc Pharmacol (1980) 0.89
5-HT receptors mediating contractions of the isolated human coronary artery. Eur J Pharmacol (1993) 0.88
Characterization of 5-HT receptors mediating constriction of porcine carotid arteriovenous anastomoses; involvement of 5-HT1B/1D and novel receptors. Br J Pharmacol (1998) 0.88
Pressor effects following microinjection of 5-HT1A receptor agonists into the raphe obscurus of the anaesthetized rat. Br J Pharmacol (1991) 0.88
High-affinity prorenin binding to cardiac man-6-P/IGF-II receptors precedes proteolytic activation to renin. Am J Physiol Heart Circ Physiol (2001) 0.88
Permeability of human isolated airways increases after hydrogen peroxide and poly-L-arginine. Am J Respir Crit Care Med (1996) 0.88
L-NAME-resistant bradykinin-induced relaxation in porcine coronary arteries is NO-dependent: effect of ACE inhibition. Br J Pharmacol (2000) 0.87
Cerebral blood flow during migraine attacks without aura and effect of sumatriptan. Arch Neurol (1995) 0.87
Effect of isometheptene on the distribution and shunting of 15 microM microspheres throughout the cephalic circulation of the cat. Headache (1980) 0.87
Different endothelin receptors involved in endothelin-1- and sarafotoxin S6B-induced contractions of the human isolated coronary artery. Br J Pharmacol (1994) 0.87
Comparison of the cardiovascular effects of the 5-HT1A receptor agonist flesinoxan with that of 8-OH-DPAT in the rat. Eur J Pharmacol (1990) 0.87
Usefulness of pimobendan in the treatment of heart failure. Arzneimittelforschung (1986) 0.87
Poor vasoconstrictor response to adrenergic stimulation in the arteriovenous anastomoses present in the carotid vascular bed of young Yorkshire pigs. Arch Int Pharmacodyn Ther (1984) 0.87
Renin-angiotensin system components in the interstitial fluid of the isolated perfused rat heart. Local production of angiotensin I. Hypertension (1997) 0.87
Localization and production of angiotensin II in the isolated perfused rat heart. Hypertension (1998) 0.87
Tumor necrosis factor-alpha enhances mRNA expression and secretion of interleukin-6 in cultured human airway smooth muscle cells. Am J Respir Cell Mol Biol (2000) 0.87
Split cervical spinal cord malformation and vertebral dysgenesis. Orthop Traumatol Surg Res (2009) 0.87
Identification and purification of murine hematopoietic stem cells by flow cytometry. Methods Cell Biol (1990) 0.86
Presynaptic inhibition by ergotamine of the responses to cardioaccelerator nerve stimulations in the cat. Eur J Pharmacol (1979) 0.86
Time dependent production of cytokines and eicosanoids by human monocytic leukaemia U937 cells; effects of glucocorticosteroids. Mediators Inflamm (1999) 0.86
Altered cardiac collagen and associated changes in diastolic function of infarcted rat hearts. Cardiovasc Res (2000) 0.86